Endothelial function is impaired in patients with primary antiphospholipid syndrome |
| |
Authors: | Stalc Monika Poredos Pavel Peternel Polona Tomsic Matija Sebestjen Miran Kveder Tanja |
| |
Affiliation: | Department of Vascular Disease, Zaloska c7, Clinical Centre, SI-1000 Ljubljana, Slovenia. monikastalc@email.si |
| |
Abstract: | INTRODUCTION: The aim of this study was to evaluate endothelial function in patients with primary antiphospholipid syndrome (PAPS). PATIENTS AND METHODS: Flow mediated (FMD) and glyceryl trinitrate (GTN) induced dilation of the right brachial artery were studied in 25 patients with PAPS and 25 controls matched by age, sex and conventional risk factors for atherosclerosis. Fibrinogen, D-dimer, adhesion molecules, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigens and activities were measured. RESULTS: Mean (SD) FMD was significantly lower in PAPS than in controls (8+/-5% vs. 15+/-6%, P<0.001); GTN-induced dilation did not differ between the groups. There was a correlation between the baseline diameter of the brachial artery and duration of the disease (-0.56, P<0.05) and between GTN induced dilation and duration of the disease (0.51, P<0.05). Concentrations of vascular cell adhesion molecule-1 (P<0.001), intracellular adhesion molecule-1 (P<0.001) and fibrinogen (P<0.05) were higher in patients than in controls but no differences were observed for D-dimer, t-PA and PAI-1 antigens and activities. There was correlation between concentration of vascular cell adhesion molecule-1 and FMD (-0.35, P<0.05) and between intracellular adhesion molecule-1 and FMD (-0.41, P<0.05). CONCLUSIONS: This study shows that endothelial function is impaired in patients with primary APS, possibly contributing to accelerated atherosclerosis and thromboembolic complications in these patients. |
| |
Keywords: | APS, antiphospholipid syndrome aPL, antiphospholipid antibodies aCL, anticardiolipin antibodies LA, lupus anticoagulant antibodies EC, endothelial cell β2GPI, beta2 glycoprotein I FMD, flow mediated vasodilation sVCAM-1, soluble vascular cell adhesion molecule-1 sICAM-1, soluble intracellular adhesion molecule-1 t-PA, tissue plasminogen activator PAI-1, plasminogen activator inhibitor-1 vWF, von Willebrand factor TF, tissue factor HDL, high density lipoprotein LDL, low density lipoprotein ELISA, enzyme-linked immunosorbent assay ACE, angiotensin-converting enzyme GTN, glyceryl trinitrate |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|